Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD

Nonalcoholic fatty liver disease (NAFLD) is a common comorbidity among people living with HIV that has a more aggressive course than NAFLD among the general population. In a recent randomized placebo-controlled trial, we demonstrated that the growth hormone–releasing hormone analog tesamorelin reduc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JCI Insight
Autori principali: Fourman, Lindsay T., Billingsley, James M., Agyapong, George, Ho Sui, Shannan J., Feldpausch, Meghan N., Purdy, Julia, Zheng, Isabel, Pan, Chelsea S., Corey, Kathleen E., Torriani, Martin, Kleiner, David E., Hadigan, Colleen M., Stanley, Takara L., Chung, Raymond T., Grinspoon, Steven K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Clinical Investigation 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7455119/
https://ncbi.nlm.nih.gov/pubmed/32701508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.140134
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi